¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"functional refractory period"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® incubation period, latent stage ÇÑ±Û Àẹ±â, ¹è¾ç±â°£
¼³¸í   
  1. º´¿øÃ¼°¡ Ã¼³»¿¡ Ä§ÀÔ(°¨¿°)ÇÑ ÈÄ ±×·Î ÀÎÇÑ °¨¿°ÁõÀÌ ¹ßº´ÇÒ ¶§±îÁöÀÇ ±â°£. º´¿øÃ¼ÀÇ Á¾·ù¿¡ µû¶ó ±× ³»¿ëÀÌ ´Ù¸£´Ù. ¿¹ÄÁ´ë ¸»¶ó¸®¾Æ´Â Ä§ÀÔÇÑ º´¿øÃ¼°¡ ÀÎü ³»¿¡¼­ ÀÏÁ¤ÇÑ ´Ü°è±îÁö ¹ßÀ°ÇÑ ÈÄ ¹ßº´Çϰí, ÀåÆ¼Çª½º´Â Ä§ÀÔÇÑ º´¿ø±ÕÀÌ ÀÏÁ¤ÇÑ ¼ö±îÁö ¹ø½ÄÀ» Çؾߠ¹ßº´Çϸç, ÆÄ»ódzÀº Ä§ÀÔÇÑ º´¿ø±ÕÀÌ »ý¼ºÇÑ µ¶¼Ò°¡ ³ú½Å°æ¿¡ ´ÞÇÑ ÈÄ¿¡ ¹ßº´ÇÑ´Ù. °°Àº º´À̶󵵠ħÀÔÇÑ º´¿øÃ¼ÀÇ ¾çÀ̳ª µ¶·Â, °¨¿°µÈ »ç¶÷ÀÇ °¨¼ö¼º µî¿¡ µû¶ó¼­µµ ´Þ¶óÁø´Ù. º¸Åë Àẹ±â¿¡´Â º´Àû Â¡Èİ¡ ³ªÅ¸³ªÁö ¾ÊÁö¸¸ ¹Î°¨ÇÑ »ç¶÷ÀÇ °æ¿ì´Â µÎÅë-½Ä¿åºÎÁø-Çö±âÁõ-ºÒÄè°¨°ú °°Àº Àü±¸Áõ»óÀ» ³ªÅ¸³»´Â ¼öµµ ÀÖ´Ù. 2. º¸¿Â±â°£, ¹è¾ç±â°£, ¹ßÀ°¿¡ ÇÊ¿äÇÑ ±â°£. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • functional refractory period
    ±â´ÉÀûºÒÀÀ±â
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • absolute refractory period
    Àý´ëºÒÀÀ±â
  • refractory period
    ºÒÀÀ±â
  • relative refractory period
    »ó´ëºÒÀÀ±â
  • refractory
    1. ºÒÀÀ-, ¹«¹ÝÀÀ¼º- 2. Ä¡·áÀúÇ×¼º-, ³­Ä¡¼º-
  • refractory investment
    ³»È­¸Å¸ôÁ¦
  • refractory normoblastic anemia
    ³­Ä¡¼ºÁ¤»óÀûÇ÷¸ð±¸ºóÇ÷
  • refractory rickets
    ºñŸ¹ÎDºÒÀÀ±¸·çº´, ºÒÀÀ¼º±¸·çº´
  • refractory state
    ºÒÀÀ»óÅÂ
  • functional amblyopia
    ±â´ÉÀÌ»ó¾à½Ã
  • functional antigen
    ±â´ÉÇ׿ø
  • functional aphasia
    ±â´É¼º¾ð¾î»ó½ÇÁõ, ±â´É¼º½Ç¾îÁõ
  • functional asplenia
    ±â´É¼ºÁö¶ó¾øÀ½(Áõ)
  • functional bleeding
    ±â´ÉÀûÃâÇ÷
  • functional blindness
    ±â´É½Ã°¢»ó½Ç
  • functional capacity
    ±â´É¿ë·®
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • refractory period
    ºÒÀÀ±â
  • functional residual capacity
    ±â´ÉÀܱâ¿ë·®
  • refractory state
    ¹«¹ÝÀÀ»óÅÂ
  • period
    ÁÖ±â
  • ejection period
    ¹ÚÃâ±â
  • incubation period
    Àẹ±â
  • induction period
    À¯µµ±â
  • involutional period
    °»³â±â
  • lag period
    Áõ½ÄÁغñ±â, Áö¿¬±â
  • latent period
    ÀáÀç±â , Àẹ±â
  • neonatal period
    ½Å»ý¾Æ±â
  • paroxysmal period
    ¹ßÀÛ±â
  • postmenopausal period
    Æó°æÈıâ
  • premenstrual period
    ¿ù°æÀü±â
  • prenatal period
    ºÐ¸¸Àü±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • functional refractory period
    ±â´ÉÀûºÒÀÀ±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • absolute refractory period
    Àý´ëºÒÀÀ±â
  • refractory period
    ºÒÀÀ±â
  • relative refractory period
    »ó´ëºÒÀÀ±â
  • normoblastic refractory anemia
    Á¤»óÀûÇ÷¸ð±¸Áö¿¬¹ÝÀÀºóÇ÷
  • refractory investment
    ³»È­¸Å¸ôÁ¦
  • platelet immunologic refractory state
    Ç÷¼ÒÆÇ¸é¿ªºÒÀÀ»óÅÂ
  • refractory rickets
    (¢¡vitamin D-resistant rickets) ºñŸ¹ÎµðÀúÇ×±¸·íº´
  • refractory state
    ¹«¹ÝÀÀ»óÅÂ
  • functional amblyopia
    ±â´ÉÀÌ»ó¾à½Ã
  • functional antigen
    ±â´ÉÇ׿ø
  • functional aphasia
    ±â´É¼º¾ð¾î»ó½ÇÁõ
  • functional asplenia
    ±â´ÉÁö¶ó¾øÀ½Áõ
  • functional residual air
    ±â´ÉÀûÀܱâ
  • functional bleeding
    ±â´ÉÃâÇ÷
  • functional blindness
    ±â´É½Ã°¢»ó½Ç, ±â´É»ö¸Í
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • absolute refractory period
    Àý´ëºÒÀÀ±â(¡­ÝÕëëÑ¢)
  • relative refractory period
    »ó´ë(Àû) ºÒÀÀ±â(ßÓÓßîÜÝÕëëÑ¢).
  • histamin refractory
    È÷½ºÅ¸¹Î¹«¹ÝÀÀ¼º(¡­ÙíÚãëëàõ)ÀÇ.
  • platelet immunologic refractory state
    Ç÷¼ÒÆÇ¸é¿ªÇÐÀû ºÒÀÀ»óÅÂ(ÝÕëëßÒ÷¾)
  • refractory investment
    ³»È­¸Å¸ôÁ¦(Ò±ûýØØÙÒð¥).
  • refractory megaloblastic anemia
    Ç×Ä¡·á¼º°ÅÀû¾Æ±¸ºóÇ÷(ùñö½èþàõËÝîåä´Ï¹Þ¸ úì).
  • refractory megaloblastic anemia
    Ç×Ä¡·á¼º°ÅÀû¾Æ±¸ºóÇ÷(ùñö½èþàõËÝîåä´Ï¹Þ¸úì)
  • refractory otalgia
    ³­Ä¡(¼º) ÀÌÅë
  • refractory otalgia
    ³­Ä¡¼º ÀÌÅë(Ññö½àõì¼÷Ô)
  • refractory rickets
    ³­Ä¡±¸·çº´(Ññö½ ׬ܻ).
  • refractory rickets
    ³­Ä¡±¸·çº´(Ññö½ ׬ܻ)
  • refractory sideroblastic anemia
    ºÒÀÀ¼ºÃ¶Àû¸ð±¸ºóÇ÷
  • refractory state
    ºÒÀÀ»óÅÂ, ¹«¹ÝÀÀ»óÅÂ
  • Oedipal period
    ¿¡µðǪ½º½Ã±â(¡­ãÁÑ¢).
  • alveolar period
    ²Ê¸®½Ã±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • absolute refractory period
    Àý´ëºÒÀÀ±â(¡­ÝÕëëÑ¢)
  • relative refractory period
    »ó´ë(Àû) ºÒÀÀ±â(ßÓÓßîÜÝÕëëÑ¢).
  • histamin refractory
    È÷½ºÅ¸¹Î¹«¹ÝÀÀ¼º(¡­ÙíÚãëëàõ)ÀÇ.
  • normoblastic refractory anemia
    À̸Ï(Ç÷¾×)Á¤Àû¸ð±¸¼º ºÒÀÀ¼º ºóÇ÷(ïáîåٽϹàõÝÕëëàõÞ¸ úì).
  • platelet immunologic refractory state
    Ç÷¼ÒÆÇ¸é¿ªÇÐÀû ºÒÀÀ»óÅÂ(ÝÕëëßÒ÷¾)
  • refractory anemia
    ºÒÀÀ¼º ºóÇ÷
  • refractory anemia
    ºÒÀÀ¼º ºóÇ÷(ÝÕëëàõÞ¸úì).
  • refractory anemia
    ºÒÀÀ¼º ºóÇ÷(ÝÕëëàõÞ¸úì)
  • refractory anemia relapsing polychondroritis
  • refractory anemia with excess blast =RAEB
    ¸ð¼¼Æ÷°ú´ÙºÒÀÀ¼ººóÇ÷
  • refractory anemia with excess blasts
    ¸ð¼¼Æ÷°ú´Ù¼º ºÒÀÀ¼ººóÇ÷
  • refractory anemia with ring sideroblast
    ȯ»óöÀû¸ð±¸(ü»ßÒôÑîåٽϹ)¼º ºÒÀÀ¼ººóÇ÷
  • refractory edema
    Ä¡·áºÒÀÀ¼º ºÎÁ¾.
  • refractory edema
    Ä¡·áºÒÀÀ¼º ºÎÁ¾(ö½ÖûÝÕÒöàõÝ©ðþ)
  • refractory investment
    ³»È­¸Å¸ôÁ¦(Ò±ûýØØÙÒð¥).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Functional deficiency
    ±â´É°áÇÌ
    [¿¾ ¿ë¾î] ±â´ÉÀû°áÇÌ
  • Functional cause
    ±â´ÉÀû¿øÀÎ
    [¿¾ ¿ë¾î] ±â´ÉÀû¿øÀÎ
  • Functional morphologic defect
    ±â´ÉÇüŰáÇÔ
    [¿¾ ¿ë¾î] ±â´ÉÀûÇüÅÂÇÐÀû°áÇÔ
  • Functional layer of endometrium
    ÀڱüӸ·±â´ÉÃþ
    [¿¾ ¿ë¾î] Àڱ󻸷±â´ÉÃþ
  • Pseudoglandular period
    °ÅÁþ»ù½Ã±â
    [¿¾ ¿ë¾î] À§¼±±â
  • Alveolar period
    ²Ê¸®½Ã±â
    [¿¾ ¿ë¾î] ÆóÆ÷±â
  • Prenatal period
    ºÐ¸¸Àü±â
    [¿¾ ¿ë¾î] ºÐ¸¸Àü±â
  • Postnatal period
    ºÐ¸¸Èıâ
    [¿¾ ¿ë¾î] ºÐ¸¸Èıâ
  • Canalicular period
    ¼¼°ü½Ã±â
    [¿¾ ¿ë¾î] ¼¼°ü±â
  • Period of mature neural groove and immature somite
    ½Å°æ°í¶û¼º¼÷ ¹× ¸öºÐÀý¹Ì¼º¼÷±â
    [¿¾ ¿ë¾î] ½Å°æ±¸Çü¼ºÈÄ±â ¹× Ã¼ÀýÇü¼ºÀü±â
  • Initial period of neural groove
    ½Å°æ°í¶ûÃʱâ
    [¿¾ ¿ë¾î] ½Å°æ±¸Çü¼ºÀü±â
  • Period of neural tube
    ½Å°æ°ü±â
    [¿¾ ¿ë¾î] ½Å°æ°ü±â
  • Neonatal period
    ½Å»ý¾Æ±â
    [¿¾ ¿ë¾î] ½Å»ý¾Æ±â
  • Intermitotic period [Interphase]
    À¯»çºÐ¿­»çÀ̱â
    [¿¾ ¿ë¾î] °£±â
  • Mesoderm of the period of branchiogenesis
    ÀεαÁÀ̹߻ý±âÁ߹迱
    [¿¾ ¿ë¾î] ÀεαÃ[»õ±Ã]¹ß»ý±âÁ߹迱
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • extrinsic incubation period
    ¸ð±â³»Àẹ±â
  • incubation period
    Àẹ±â
  • latent period
    Àẹ±â
  • prepatent period
    ÃæÃ¼Àẹ±â
  • residual period
    ÀÜ·ù±â°£
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • refractory prriod
    ºÒÀÀ±â(Ñ¢)
  • functional group
    ÀÛ¿ë±â(íÂéÄÐñ)
  • functional group isomer
    ÀÛ¿ë±â(íÂéÄÐñ) À̼ºÃ¼(ì¶àõô÷)
  • conversion period
    Àüȯ±â°£(ï®üµÑ¢Êà)
  • half-period
    ¹Ý±â°£(ÚâÑ¢Êà)
  • incubation period
    Àẹ±â(íÖÜÑÑ¢)
  • induction period
    À¯µµ±â°£(ë¯ÓôÑ¢Êà)
  • lag period
    Áöü½Ã°£(òÀôòãÁÊà)
  • latent period
    Àẹ±â(íÖÜÑÑ¢)
  • long period intersperion
    Àå±â »êÀç(íþѢߤî¤)
  • short period intespersion
    ´Ü±â°£ »êÀç(Ó­Ñ¢Êàߤî¤)
  • unit evolutionary period
    ´ÜÀ§(Ó¤êÈ) ÁøÈ­±â°£ (òäûùÑ¢Êà)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • incubation period
    Àẹ±â, º¸¿Â±â°£, ¹è¾ç±â°£
  • latent period
    Àẹ±â, Àẹ½Ã, ÀáÀڱؽÃ, Àẹ±â°£
  • period
    ÁÖ±â, ±â, ±â°£, ½Ã´ë
  • pulse repetition period
    ÆÞ½º¹Ýº¹ÁÖ±â
  • functional bleeding
    ±â´ÉÀûÃâÇ÷
  • functional brain imaging
    ±â´ÉÀû³ú¿µ»ó
  • functional magnetic resonance imaging [=fMRI]
    ±â´ÉÀûÀÚ±â°ø¸í¿µ»ó
  • functional scoliosis
    ±â´É¼ºÃ´ÃßÃø¸¸Áõ
  • magnetic resonance functional neuroimaging [=MRFN]
    ÀÚ±â°ø¸í±â´ÉÀû³ú¿µ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HFRS Hemorrhagic Fever with Renal Syndrome [HP 849-50]
  = Korean Hemorrhagic Fever
&nbs...
AERP antegrade effective refractory period; atrial effective refractory period
ARP absolute refractory period; American Registry of Pathologists; anticipated recovery path; apolipopro...
AVNFRP atrioventricular node functional refractory period
FRP follicle-stimulating hormone releasing protein; functional refractory period
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FRP functional refractory period
AERP Atrial effective refractory period
ERP Effective refractory period
PRP Psychological Refractory Period
RP Refractory Period
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • refractory cast
    ³»È­¼º ¸ðÇü
    ºÐÇØµÇÁö ¾Ê°í °í¿­À» °ßµô ¼ö ÀÖ´Â Àç·á·Î ¸¸µé¾îÁø ¸ðÇüÀ¸·Î¼­, ±¹¼Ò ÀÇÄ¡ ÁÖÁ¶¼ú¿¡ »ç¿ëµÉ ¶§ ÆØÃ¢ÇÏ¿© ±Ý¼ÓÀÇ ¼öÃàÀ» º¸»óÇÑ´Ù.
  • refractory investment
    ³»È­ ¸Å¸ôÁ¦, ³»È­¼º ¸Å¸ôÀç
    ³³ÂøÀ̳ª ÁÖÁ¶¿¡ »ç¿ëµÇ´Â °í¿Â¿¡ °ßµô¼ö ÀÖ´Â ¸Å¸ôÀç.
  • refractory mold
    ³»È­¼º ¸ôµå
  • sideroblastic refractory anemia
    ö Àû¸ð±¸¼º ºÒÀÀ¼º ºóÇ÷
  • functional abnormality
    ±â´ÉÀû ÀÌ»ó
  • functional amblyopia
    ±â´É ¾à½Ã
  • functional aphasia
    ±â´É¼º ½Ç¾î
    È÷½ºÅ׸® ¶Ç´Â ÁßÁõ È÷½ºÅ׸®¼º Àå¾Ö¿¡ ±âÀÎÇÑ ½Ç¾îÁõ.
  • functional articulation
    ±â´É ±³ÇÕ
  • functional brain imaging
    ±â´ÉÀû ³ú ¿µ»ó
  • functional dead space
    ±â´ÉÀû »ç°­
  • functional disc dislocation
    °üÀý¿øÆÇÀÇ ±â´ÉÀû ÀüÀ§
  • functional disc displacement
    ±â´ÉÀû °üÀý¿øÆÇ º¯À§
  • functional dislocation with reduction
    Á¤º¹¼º ±â´ÉÀû ÀüÀ§
  • functional displacement
    ±â´ÉÀû º¯À§
  • functional endoscopic sinus surgery
    ±â´ÉÀû ³»½Ã°æ ºÎºñµ¿ ¼ö¼ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
functional refractory period The minimum interval possible between successive responses to stimulation of a tissue.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
absolute refractory period The period following excitation when no response is possible regardless of the intensity of the stimulus.
(05 Mar 2000)
refractory period <neurology, physiology> most commonly used in reference to the interval (typically 1ms) after the passage of an action potential during which an axon is incapable of responding to another. This is caused by inactivation of the sodium channels after opening. The maximum frequency at which neurons can fire is thus limited to a few hundred Hertz. An analogous refractory period occurs in individuals of Dictyostelium discoideum, which are insensitive to extracellular cyclic AMP immediately after a pulse of cAMP has been secreted.
The term can be applied to any system where a similar insensitive period follows stimulation.
(18 Nov 1997)
refractory period of electronic pacemaker The time required to restore full sensitivity after detecting cardiac activity or delivering a pacing impulse.
(05 Mar 2000)
refractory period, psychological A delayed response interval occurring when two stimuli are presented in close succession.
(12 Dec 1998)
relative refractory period The period between the effective refractory period and the end of the refractory period; fibres then respond only to high intensity stimuli and the impulses conduct more slowly than normally.
(05 Mar 2000)
effective refractory period The period during which impulses may appear but are too weak to be conducted; the longest interval between adequate stimuli, falling just short of the time necessary to allow a propagated response to be evoked in a tissue by the second stimulus; it differs from the functional refractory period in that it is a measure of stimulus interval rather than response interval of time.
(05 Mar 2000)
total refractory period The absolute refractory period plus the relative refractory period.
(05 Mar 2000)
anaemia, refractory Anaemia (a shortage of red blood cells) unresponsive to treatment.
(12 Dec 1998)
anaemia, refractory, with excess of blasts Chronic refractory anaemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells.
(12 Dec 1998)
refractory Not readily yielding to treatment.
Origin: L. Refractorius
(18 Nov 1997)
refractory anaemia <haematology> A form of myelodysplasia which primarily affects the red cell production by the bone marrow.
In some cases the developing red cells show an internal ring of iron granules. These cells are called sideroblasts. Refractory anaemia and refractory anaemia with sideroblasts are the most common forms of myelodysplasia.
Origin: Gr. Haima = blood
(13 Nov 1997)
refractory anaemia with excess blasts <haematology> A form of myelodysplasia characterised by the build up of immature white blood cells (blasts) in the bone marrow.
If the immature cells are particularly numerous it may indicate a chance of transformation to acute leukaemia and the condition is called refractory anaemia with excess blasts in transformation (RAEBt).
Acronym: RAEB
(13 Nov 1997)
refractory cast A cast made of material that will withstand the high temperatures of metal casting or soldering without disintegrating.
Synonym: investment cast.
(05 Mar 2000)
refractory flask A metal tube in which a refractory mold is made for casting metal dental restorations or appliances.
Synonym: casting flask, casting ring.
(05 Mar 2000)
refractory lining A lining, usually of ceramic, capable of resisting and maintaining high temperatures.
(05 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • refractory
    ´Ù·ç±â Èûµç; ³­Ä¡ÀÇ
  • refractory
    (»ç¶÷.µ¿¹° µîÀÌ)°¨´çÇÒ ¼ö ¾ø´Â;´Ù·ç±â Èûµå´Â;¼øÁ¾ÇÏÁö ¾Ê´Â;³­Ä¡ÀÇ;¿Ï°íÇÑ;(º´ µî¿¡)ÀúÇ× ÇÒ ¼ö ÀÖ´Â;º´µ¶¿¡ °¨¿°µÇÁö ¾Ê´Â;(±Ý¼Ó µîÀÌ)¿ëÇØ(ó¸®)Çϱ⠾î·Á¿î;(º®µ¹ µîÀÌ)³»È­¼ºÀÇ;³»È­ ¹°Áú;³»È­ º®µ¹;-riness
  • functional calculus
    =PREDICATE CALCULUS
  • functional change
    ±â´É Àüȯ
  • functional illiterate
    ±â´ÉÀû ¹®¸ÍÀÚ
  • functional illiterate
    Àбâ;¾²±âÀÇ ´É·ÂºÎÁ·À¸·Î »çȸ»ýȰ¿¡ ÁöÀåÀÌÀÖ´Â »ç¶÷
  • functional representation
    Á÷´É ´ëÇ¥Á¦
  • functional shift
    ±â´É Àüȯ
  • period
    ±â°£,½Ã´ë,Á¾ÁöºÎ
  • cooling-off period
    ³Ã°¢ ±â°£
  • glacial epoch(period)
    ºùÇϱâ(½Ã´ë)
  • glacial period
    ºùÇÏ ½Ã´ë
  • grace period
    À¯¿¹±â°£
  • halflife period
    (¹æ»ç¼º ¿ø¼Ò µîÀÇ)¹Ý°¨±â
  • honeymoon period
    (¹Ì)(´ëÅë·É ÃëÀÓÈÄ ¾à 3°³¿ù°£ÀÇ È£ÀǸ¦ ¹Þ´Â)¹Ð¿ù ±â°£
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á